NAPRT silencing in FH-deficient renal cell carcinoma confers therapeutic vulnerabilities via NAD+ depletion
Ontology highlight
ABSTRACT: NAPRT silencing in FH-deficient renal cell carcinoma confers therapeutic vulnerabilities via NAD+ depletion
PROVIDER: PRJNA1122776 | ENA |
REPOSITORIES: ENA
ACCESS DATA